VCEL

#2057
Vericel Corporation
35.1400 USD
+2.03%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
35.1400
35.1400
Jahresspanne
28.9500
43.0000
Tagesänderung
+2.03%
Monatliche Änderung
+7.17%
6 month change
-3.33%
Jahresänderung
-3.33%
Vorheriger Schlusskurs
34.4400
Eröffnung
35.1400
Bid
Ask
Tief
35.1400
High
35.1400
Volumen
65
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 1.7838 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
112.53
Preis-Umsatz-Verhältnis
6.8

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Nachrichten